TIAA CREF Investment Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

TIAA CREF Investment Management’s Portfolio MBII Stock Details MBII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$81K	Buy	52,950 +38	+0.1%	+$58	﹤0.01%	2973
2018 Q4	$78K	Hold	52,912	–	–	﹤0.01%	2979
2018 Q3	$97K	Sell	52,912 -30,862	-37%	-$59.9K	﹤0.01%	3036
2018 Q2	$154K	Buy	+83,774	New	+$156K	﹤0.01%	3055
2015 Q2	–	Sell	-43,898	Closed	-$170K	–	3230
2015 Q1	$170K	Hold	43,898	–	–	﹤0.01%	3070
2014 Q4	$158K	Hold	43,898	–	–	﹤0.01%	3107
2014 Q3	$117K	Buy	43,898 +632	+1%	+$4.22K	﹤0.01%	3101
2014 Q2	$503K	Buy	43,266 +30,221	+232%	+$342K	﹤0.01%	3008
2014 Q1	$182K	Hold	13,045	–	–	﹤0.01%	3080
2013 Q4	$232K	Buy	13,045 +2,690	+26%	+$43.7K	﹤0.01%	3076
2013 Q3	$174K	Buy	+10,355	New	+$145K	﹤0.01%	3064

Other funds holding MBII

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IAM

ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

TIAA CREF Investment Management's MBII Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Marrone Bio Innovations, Inc. (MBII) stake by 0.07% in Q1 2019, buying an estimated $58 and bringing the position to 52,950 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #2973.

TIAA CREF Investment Management first reported a position in MBII in Q3 2013 and has held it in 11 quarters since. The position peaked at $503K in Q2 2014. 53 funds tracked by Wall St. Rank hold MBII as of Q1 2019.

TIAA CREF Investment Management held 52,950 shares of Marrone Bio Innovations, Inc. worth $81K as of Q1 2019.
TIAA CREF Investment Management bought 38 Marrone Bio Innovations, Inc. shares in Q1 2019, an estimated $58.
Marrone Bio Innovations, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2973 holding.
TIAA CREF Investment Management first reported a position in Marrone Bio Innovations, Inc. in Q3 2013 and has held it in 11 quarters since.
TIAA CREF Investment Management's Marrone Bio Innovations, Inc. position peaked at $503K in Q2 2014.
53 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.